Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
| Role | Insider | Date | Transaction | Value | Shares |
|---|---|---|---|---|---|
| Chief Operating Officer | Notman Donald | Aug 31, 2026 | Sell | $11.25K | 1,099 |
| Chief Development Officer | Kaiser Peter | Aug 24, 2026 | Sell | $32.69K | 3,035 |
| Chief Scientific Officer | Heier Jeffrey S. | Aug 24, 2026 | Sell | $35.53K | 3,296 |
| Director | Dugel Pravin | Aug 24, 2026 | Sell | $233.16K | 21,649 |
| Chief Strategy Officer | Nayak Sanjay | Aug 24, 2026 | Sell | $20.45K | 1,897 |
| Chief Medical Officer | Waheed Nadia | Jun 3, 2026 | Sell | $122.63K | 14,828 |
| Chief Development Officer | Kaiser Peter | May 26, 2026 | Sell | $24.33K | 2,967 |
| Chief Scientific Officer | Heier Jeffrey S. | May 26, 2026 | Sell | $24.75K | 3,018 |
| Chief Strategy Officer | Nayak Sanjay | May 26, 2026 | Sell | $15.24K | 1,858 |
| Director | Dugel Pravin | May 26, 2026 | Sell | $173.48K | 21,156 |
| Chief Strategy Officer | Nayak Sanjay | Feb 23, 2026 | Sell | $14.56K | 1,759 |
| Chief Development Officer | Kaiser Peter | Feb 23, 2026 | Sell | $23.27K | 2,810 |
| Chief Scientific Officer | Heier Jeffrey S. | Feb 23, 2026 | Sell | $25.31K | 3,057 |
| Director | Dugel Pravin | Feb 23, 2026 | Sell | $166.06K | 20,056 |
| Chief Medical Officer | Waheed Nadia | Feb 20, 2026 | Sell | $27.17K | 3,510 |
| Director | LINDSTROM RICHARD L MD | Feb 20, 2026 | Buy | $461.35K | 60,229 |
| Chief Medical Officer | Waheed Nadia | Feb 12, 2026 | Sell | $71.08K | 7,863 |
| Director | Dugel Pravin | Feb 12, 2026 | Sell | $1.13M | 124,882 |
| Chief Strategy Officer | Nayak Sanjay | Feb 12, 2026 | Sell | $93.55K | 10,348 |
| Chief Operating Officer | Notman Donald | Feb 12, 2026 | Sell | $103.47K | 11,446 |
| Chief Operating Officer | Notman Donald | Feb 4, 2026 | Sell | $51.54K | 6,035 |
| Chief Operating Officer | Notman Donald | Feb 2, 2026 | Sell | $49.86K | 5,455 |
| Director | Dugel Pravin | Nov 24, 2025 | Sell | $235.14K | 19,530 |
| Chief Scientific Officer | Heier Jeffrey S. | Nov 24, 2025 | Sell | $41.77K | 3,469 |
| Chief Strategy Officer | Nayak Sanjay | Nov 24, 2025 | Sell | $22.61K | 1,878 |
Open-market purchases and sales reported on SEC form 4 over the last 10years. Awards, option exercises, gifts and other non-market form 4 activity are excluded. Chart markers group a day's filings by direction; the table lists each filing.
